FAQ: Best practices to accelerate the time to finding the right therapy for your patients with IBS-C?

Thank you to Ardelyx for your support of this FAQ Video Module.

In this FAQ Video Module, Kim Orleck, PA-C, from Atlanta Gastroenterology Associates, discusses best practices to accelerate the process of identifying the right therapy for patients with Irritable Bowel Syndrome with Constipation (IBS-C). A timely and accurate diagnosis is the foundation for effective treatment, helping reduce unnecessary testing, lower financial burdens, and get patients on the right therapy as quickly as possible.

One of the most significant advancements in managing IBS-C is the shift to a positive diagnostic strategy. Rather than relying on extensive exclusion-based testing, this approach allows providers to confidently diagnose IBS-C sooner, reducing diagnostic delays and improving patient outcomes. A faster diagnosis leads to earlier treatment, which not only improves symptoms sooner but also builds patient trust and confidence in their healthcare provider.

Once patients begin therapy, follow-up at 2-3 months is essential to assess both bowel symptom improvement and global symptom relief. If a patient has not achieved their therapeutic goals by this time, providers should reevaluate treatment options and consider alternative therapies. Factors influencing treatment selection include dosing frequency (once daily vs. multiple doses per day), timing of medication in relation to meals, side effect profile and individual patient tolerance, patient preferences and lifestyle considerations.

Shared decision-making is crucial in selecting the best treatment for IBS-C. Involving patients in the discussion helps ensure better adherence and satisfaction with the prescribed therapy. Additionally, cost and insurance coverage should always be factored into the treatment plan to avoid delays in access to medications. Keeping detailed records of previous treatment trials and patient responses helps prevent unnecessary medication switches and streamlines insurance approvals.

By adopting a structured and patient-centered approach, providers can significantly reduce the time to effective IBS-C treatment, enhance patient-provider relationships, and improve long-term management of IBS-C symptoms.

For more expert insights on IBS-C diagnosis, treatment strategies, and patient management, visit the GHAPP website or download the GHAPP ACE mobile app.